1-[4-[2-[3-(dimethylamino)azetidin-1-yl]-8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-ethyl-1H-indazol-4-yl)oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one
C99H100F6N32O8 — CID 157467130
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[2-[3-(dimethylamino)azetidin-1-yl]-8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-ethyl-1H-indazol-4-yl)oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one
1-[4-[2-[3-(dimethylamino)azetidin-1-yl]-8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-ethyl-1H-indazol-4-yl)oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one (PubChem CID 157467130) has the molecular formula C99H100F6N32O8 and a molecular weight of 1980.09 g/mol. Its IUPAC name is 1-[4-[2-[3-(dimethylamino)azetidin-1-yl]-8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-ethyl-1H-indazol-4-yl)oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one.
Molecular Properties
| Compound Name | 1-[4-[2-[3-(dimethylamino)azetidin-1-yl]-8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-ethyl-1H-indazol-4-yl)oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one |
|---|---|
| PubChem CID | 157467130 |
| Molecular Formula | C99H100F6N32O8 |
| Molecular Weight | 1980.09 g/mol |
| Exact Mass | 1978.83 |
| IUPAC Name | 1-[4-[2-[3-(dimethylamino)azetidin-1-yl]-8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-ethyl-1H-indazol-4-yl)oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[[5-(trifluoromethyl)-1H-indazol-4-yl]oxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one |
| SMILES | C=CC(=O)N1CCN(c2nc(N3CC(N(C)C)C3)nc3c(Oc4c(C(F)(F)F)ccc5[nH]ncc45)nccc23)CC1.C=CC(=O)N1CCN(c2nc(N3CCN(C)CC3)nc3c(Oc4c(C)ccc5[nH]ncc45)nccc23)CC1.C=CC(=O)N1CCN(c2ncnc3c(Oc4c(C(F)(F)F)ccc5[nH]ncc45)nccc23)CC1.C=CC(=O)N1CCN(c2ncnc3c(Oc4c(CC)ccc5[nH]ncc45)nccc23)CC1 |
| InChI | InChI=1S/C27H28F3N9O2.C27H31N9O2.C23H23N7O2.C22H18F3N7O2/c1-4-21(40)37-9-11-38(12-10-37)24-17-7-8-31-25(22(17)33-26(34-24)39-14-16(15-39)36(2)3)41-23-18-13-32-35-20(18)6-5-19(23)27(28,29)30;1-4-22(37)34-13-15-35(16-14-34)25-19-7-8-28-26(38-24-18(2)5-6-21-20(24)17-29-32-21)23(19)30-27(31-25)36-11-9-33(3)10-12-36;1-3-15-5-6-18-17(13-27-28-18)21(15)32-23-20-16(7-8-24-23)22(26-14-25-20)30-11-9-29(10-12-30)19(31)4-2;1-2-17(33)31-7-9-32(10-8-31)20-13-5-6-26-21(18(13)27-12-28-20)34-19-14-11-29-30-16(14)4-3-15(19)22(23,24)25/h4-8,13,16H,1,9-12,14-15H2,2-3H3,(H,32,35);4-8,17H,1,9-16H2,2-3H3,(H,29,32);4-8,13-14H,2-3,9-12H2,1H3,(H,27,28);2-6,11-12H,1,7-10H2,(H,29,30) |
| InChIKey | BUPOOIYZCWBQKQ-UHFFFAOYSA-N |
| XLogP | 12.52 |
| TPSA | 413.48 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 145 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1980.09 |
| LogP ≤ 5 | 12.52 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 32 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157467130 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.